Company News | May 7, 2023
Original article published at Dentistry 33 The ISPOR’s 2023 annual global conference — with a theme of Impacting Innovation, Value and Healthcare Decision Making — convenes thought leaders to discuss how we establish, incentivize and share value sustainable for health systems, patients and technology developers. Billed as the leading global conference for health economics and outcomes research, the conference takes place May 7 to 10, virtually and in-person in Boston. Organizers said attendees will be primed for discussion and speakers will disseminate the latest trends in health care. Topics to be covered at ISPOR include: Clinical outcomes Epidemiology and public health Economic evaluation Health policy and regulatory issues Health technology assessment Health service delivery and process of care Medical technologies Patient-centered research Real-world data and information systems Study approaches Methodological and statistical research Organizational practices During the event, RxData and Edra Publishing will unveil a new book, “Patient-Reported Outcome Measures,” written by Dr. Giuseppe Banfi, MD, and researcher Federico Pennestrì. In the new book, the authors conclude that increasing investments in health care do not necessarily produce corresponding improvements in the perceived health of their recipients, whether individual patients or society. Banfi and Pennestrì explore how to quantify health regained by patients, how to measure what matters to patients when physical health is not fully recoverable and how to help physicians and administrators identify the correct objectives and improvements. They also describe what scientific instruments can estimate the best routes for patients and people given the allocation of limited resources. The authors discuss the development of Patient Reported Outcome Measurements (PROMs) which help answer many of these challenges, offering a standardized tool to quantify and qualify the effectiveness of health interventions from the point of view of patients. This book provides an introductory framework to the science of patient-reported experience and outcomes, illustrating the need for them, their main applications and some significant national and international studies. The duo also analyzes limitations and opportunities for development in the new book. The aim is to raise the awareness of practitioners, patients and students of their use in day-to-day practice, with an additional goal of contributing today to the development of the medicine of tomorrow. Banfi is a professor of clinical biochemistry and clinical molecular biology at Università Vita e Salute San Raffaele of Milan and scientific director of the Scientific Institute for Research, Hospitalization and Healthcare (IRCCS) in Milan, Italy. Pennestrì is a postdoctoral researcher at the IRCCS, a title granted by the Italian Department of Health to a limited number of institutes in the country. The organization is committed to developing benchmarks for the public health system for the quality of patient care and innovation in the field of organization. About ISPOR ISPOR believes that every healthcare decision should be informed by the best scientific research derived from rigorous, proven methodologies. The Society was founded in 1995 by a small group of dedicated volunteers and visionaries with the goal of serving as a catalyst for advancing the science and practice of health economics and outcomes research worldwide. The Society’s dedicated volunteer leaders make ISPOR’s work possible — from its Board of Directors to the many volunteer leaders across the globe who contribute to the Society’s working groups, councils, and global engagement groups. Additionally, many ISPOR members are experts and thought leaders in the field who contribute to the reports, tools, and other HEOR resources made freely available by the Society. ISPOR is a nonprofit organization that welcomes all healthcare stakeholders as members, including researchers, academicians, regulators and assessors, public and private payers, healthcare providers, industry, and patient representatives. Learn more at https://www.ispor.org/ About RxData RxData is a leading global market access data company, providing fast and reliable insights on life science commercialization. With the largest on-demand and automated database of pharmaceutical product prices and reimbursement decisions, it has never been easier to navigate the many complexities facing pharmaceutical commercialization. RxData empowers life science companies of all sizes to go-to-market faster, plan launches, price products and steer clinical and HEOR teams towards the best possible worldwide access. Learn more at www.rxdata.net About Edra Publishing Edra Publishing US LLC is the American branch of EDRA – LSWR GROUP, the multinational group focused on evolving the professional knowledge in both medical and legal communities, dreaming of innovative solutions for the future of healthcare. Edra offers novel approaches to deliver value in health care and, with over 700 skilled professionals, operates via its offices in 10 countries and markets its products and solutions in 65 countries around the world. Visit www.edrapublishing.com
